This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
03/27/15 - 1:30:44 PM ET (BATS BZX Real-time Price)
Div Yield: --
IART Day's Range
IART 52 Week Range
IART Business Summary
Integra LifeSciences Holdings Corporation develops, manufactures, and markets surgical implants and medical instruments for use in neurosurgery, extremity reconstruction, orthopedics, and general surgery. The company operates in five segments: U.S. Neurosurgery; U.S. Extremities; U.S.View IART key stats
Report Summary: TheStreet Ratings team rates Integra Lifesciences Holdings Corp as a
Buy with a ratings score of B+.
Report Snippet: We rate Integra Lifesciences Holdings Corp (IART) a Buy.
This is based on the convergence of positive investment measures, which should help this stock outperform the majority
of stocks that we rate. The company's strengths can be seen in multiple areas, such as its solid stock price performance,
growth in earnings per share, revenue growth, notable return on equity and expanding profit margins. Although the company
may harbor some minor weaknesses, we feel they are unlikely to have a significant impact on results.